+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 15 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are investigating treatments for symptoms related to mild traumatic brain injury mTBI, particularly in military service members who experience lasting symptoms such as dizziness, headache, and cognitive issues. This clinical trial compares Acceptance and Commitment Therapy Integrated Rehabilitation ACT, a therapy combining mindfulness and behavioral techniques, with usual care rehabilitation. The goal is to see if the combined ACT and rehabilitation approach improves symptom relief and functional recovery more effectively than usual care alone. Participants will be randomly assigned to one of two groups. One group receives the ACT intervention, which includes weekly in-person therapy sessions over four weeks plus daily at-home activities focusing on psychological flexibility and goal setting alongside targeted vestibular therapy and behavioral management strategies. The other group receives usual care rehabilitation tailored to individual needs, including therapies such as vestibular rehabilitation, neuropsychology, physical therapy, and general mental health support, but without ACT components. During the study, participants will be evaluated at baseline, after the 4-week treatment, and then at 3 and 6 months post-treatment. Assessments include questionnaires measuring anxiety, neurobehavioral symptoms, dizziness, mood, PTSD symptoms, disability, and activity levels, as well as objective measures like eye movement tracking and physical activity monitoring using Fitbit devices. This allows researchers to monitor symptom changes, functional improvements, and overall health throughout and after the treatment period.

Age: 18Years - 49YearsAll GendersPhase Not Applicable
2 locations
R

Actively Recruiting

This research aims to quickly reduce suicidal thoughts in adults aged 18 to 70 who come to the Emergency Department with serious thoughts or behaviors of self-harm and are expected to be admitted to the hospital for suicidality. The study evaluates the combination of an intramuscular injection of ketamine and a short psychological intervention called Crisis Response Planning CRP compared to placebo injections and standard safety planning. The goal is to find effective emergency treatments for acute suicidal ideation. Participants will be randomly assigned to one of four groups ketamine with CRP, ketamine with safety plan control, placebo with CRP, or placebo with safety plan control. The ketamine dose is 1 mgkg given by injection in the Emergency Department, followed by monitoring for side effects and vital signs for one hour. The CRP therapy is a single 45-60 minute session provided by a trained therapist, while the safety plan control is given as standard care at hospital discharge. During the study, participants will complete assessments at baseline, and follow-ups at 24 hours, 48 hours, 72 hours, 7 days, 28 days, and 56 days after treatment either in person or by phone. Researchers will measure suicidal thoughts and depressive symptoms using validated scales such as the Depressive Symptoms Index - Suicidality Subscale and the Suicide Visual Analogue Scale. Safety monitoring will occur during and after the initial treatment period to track side effects and overall participant well-being.

Age: 18Years - 70YearsAll GendersPhase 2
2 locations
C

Actively Recruiting

This research aims to find out if adding Crisis Response Planning CRP, a brief strategy to help manage emotional crises, to massed Cognitive Processing Therapy CPT, a talk therapy for posttraumatic stress disorder PTSD, can better reduce suicidal thoughts and behaviors. The study focuses on military personnel and veterans with PTSD or subthreshold PTSD who have experienced recent suicidal ideation or attempts. It builds on earlier findings suggesting that combining CRP with CPT may improve outcomes for those facing both PTSD symptoms and suicide risk. Participants will be randomly assigned to one of two groups one receiving massed CPT plus CRP, and the other receiving massed CPT plus usual care suicide risk management, which involves a standard safety planning procedure. All participants will attend 10 daily CPT sessions over two consecutive weeks. The suicide risk intervention, whether CRP or usual care, is introduced during the intake session and reviewed during treatment. Optional booster sessions are also available. Throughout the study, participants will complete baseline assessments, daily therapy sessions, and ecological momentary assessment EMA surveys for four weeks. Follow-up assessments will occur at 1, 3, 6, 9, and 12 months after treatment. Researchers will monitor PTSD symptoms using the PTSD Checklist for DSM-5 and track suicidal thoughts and behaviors with several interviews and scales. The study aims to identify early indicators of treatment response and understand which parts of CRP are most helpful to participants. Safety and progress will be carefully observed during and after the study period.

Age: 18Years +All GendersPhase Not Applicable
1 location
S

Actively Recruiting

Healthy Volunteer

This clinical trial focuses on military service members or retirees aged 18 to 65 with post-traumatic stress disorder PTSD. It aims to compare the effects of combining Massed Prolonged Exposure PE, a type of behavioral therapy for PTSD, with a stellate ganglion block SGB, which is an injection of a local anesthetic in the neck, against Massed PE combined with a sham injection. The study also seeks to understand how differences in psychophysiological responses during the exposure therapy relate to treatment outcomes. Participants will receive ten 90-minute Massed PE sessions conducted by qualified therapists over two weeks, Monday through Friday, involving about four to six hours of treatment daily including therapy and out-of-session assignments. Between the first and second PE sessions, participants will be randomly assigned to receive either a one-time SGB injection using 6.5cc of Ropivacaine or a sham injection of normal saline. After the initial treatment, participants may have three booster sessions offered at 1, 3, and 7 weeks post-treatment. Qualified medical personnel will administer the injections under standard procedures with monitoring during and after the procedure. Throughout the study, participants will undergo assessments before, during, and after treatment, including follow-ups at 1, 3, and 6 months after completing PE. The main outcomes measured include changes in PTSD symptoms using the Clinician-Administered PTSD Scale and the PTSD Checklist. Additional evaluations include questionnaires on depression, anxiety, and trauma-related thoughts, as well as psychophysiological measures such as skin response, heart rate, and movement during the two-week treatment period. Participants in the sham injection group will be offered the active SGB after the one-month assessment. The total study duration includes treatment and follow-up assessments lasting several months.

Age: 18Years - 65YearsAll GendersPhase 2
2 locations
I

Actively Recruiting

Healthy Volunteer

This research aims to enhance resiliency and optimize readiness in military personnel, specifically targeting soldiers in the 3rd Security Force Assistance Brigades SFABs. These specialized Army units operate under high stress and demanding conditions, requiring strong individual resiliency. The study compares a new Acceptance and Commitment Training ACT-based program with usual resilience training to see how well each supports psychological flexibility and readiness during training and deployment. The trial is sponsored by The University of Texas Health Science Center at San Antonio and involves 600 soldiers stationed at Fort Hood, Texas. Participants will be randomly assigned to one of two groups. One group receives the standard resilience training called Master Resilience Trainer MRT, focusing on mental toughness and character strengths without booster sessions. The other group attends a 2-day psychological flexibility training workshop based on ACT, which teaches acceptance, mindfulness, and coping strategies to improve adaptability under stress. This group may also join four optional monthly booster sessions to reinforce the training concepts. Throughout the 16-month study period, soldiers will complete assessments measuring resilience using the Connor-Davidson Resilience Scale CD-RISC at baseline, after training, before deployment, and at regular 4-month intervals. The study tracks psychological flexibility, coping skills, and stress adaptation to evaluate training effects. Researchers will monitor participants ability to maintain readiness and adapt positively to operational stressors during and after deployment.

Age: 18Years +All GendersPhase Not Applicable
1 location
L

Actively Recruiting

Healthy Volunteer

Researchers are studying the Life Force training program, a group-based skills training designed for active-duty Soldiers. This program aims to enhance mental toughness and reduce harmful and high-risk behaviors. The study compares participants who receive the training to those in a control group to see who benefits most from these skills-based strategies. The training focuses on key skills like support building, persistence, adversity management, accountability, and emotional control. Participants are randomly assigned to either the Life Force training group or a control group. The training group attends five group sessions led by skilled trainers, while the control group receives standard care without training. Both groups complete a baseline survey and follow-up surveys at 6 and 12 months. Surveys gather information on risky behaviors, performance, mental toughness, military readiness, job satisfaction, career plans, and overall role functioning. Throughout the study, participants complete 15-20 minute surveys assessing their behaviors and functioning over a 12-month period following the baseline. An AI algorithm is used to identify those most likely to benefit from the training. The research team monitors outcomes related to high-risk behaviors, performance, mental toughness, and suicide-related behaviors to evaluate the programs impact compared to no intervention.

Age: 18Years +All GendersPhase Not Applicable
1 location
L

Actively Recruiting

Researchers are investigating the long-term safety and effectiveness of Abbotts neurostimulation systems in people with chronic pain. This observational study includes a wide range of participants to reflect real-world use and aims to enroll up to 2,000 subjects across up to 100 centers. The study spans 13 years, covering enrollment, data collection, and study closure, with subjects followed for five years after implantation. Participants will receive one of Abbotts market-released neurostimulation devices, either spinal cord stimulation SCS or dorsal root ganglion stimulation DRG. Individuals scheduled for implantation within 60 days of baseline are eligible. The study is single-arm and open-label, meaning all participants receive the device without randomization or placebo control. During the study, researchers will monitor adverse events, deaths, and device issues at multiple time points from baseline through five years post-implant. Participants will undergo regular safety assessments and provide data on device performance and related outcomes. This comprehensive follow-up will help understand the long-term effects and real-world use of these neurostimulation systems.

Age: 18Years +All Genders
55 locations
M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations
P

Actively Recruiting

Researchers are investigating treatments for chronic posttraumatic headache PTH in military service members and veterans who have experienced traumatic brain injury TBI. The study compares the effects of Clinic-based Cognitive Behavioral Therapy CCBT, Telemedicine-based Cognitive Behavioral Therapy TCBT, and treatment as usual TAU in reducing headache-related disability. This trial aims to confirm whether telemedicine delivery of CBT is as effective as in-person therapy and to replicate previous findings across multiple sites. Participants will be randomly assigned to one of three groups CCBT, which involves 8 weekly face-to-face sessions TCBT, which provides 8 weekly CBT sessions via telemedicine with additional procedures for safety and technical support or TAU, where participants continue their usual medical care for 8 weeks. The study is conducted at several VA medical centers and military treatment facilities across the U.S., with some sites limiting randomization to TCBT and TAU. During the study, participants will be assessed multiple times for headache-related disability using the Headache Impact Test HIT-6, headache experience, and mental health conditions such as depression, anxiety, and PTSD. Safety and adverse events are monitored, especially in the TAU group. The total timeline includes baseline, 3-month follow-up, and ongoing monitoring to evaluate treatment outcomes and patient perspectives on therapy experience.

Age: 18Years - 70YearsAll GendersPhase Not Applicable
8 locations
N

Actively Recruiting

Researchers are evaluating a non-trauma based treatment designed specifically for military veterans and service members who have mild or moderate traumatic brain injuries TBI and co-occurring posttraumatic stress disorder PTSD. The goal is to test this treatment called Non-Trauma Treatment for TBI and PTSD T3 PTSD to see if it is acceptable and feasible for this group seeking care at Fort Hood, Texas. This study aims to improve care options for those affected by both TBI and PTSD through focused psychotherapy. The treatment involves eight individual psychotherapy sessions, each lasting about 45 to 75 minutes. These sessions include relaxation training, identifying stress, stress management techniques, and problem-solving skills. Participants receive this behavioral intervention tailored to their needs, with the study tracking outcomes from baseline through six months after treatment. The intervention is delivered in a clinical setting at the Intrepid Spirit Center for eligible veterans and active duty members. Participants will be involved in assessments at the start of the study and throughout an approximately eight-month period, including follow-up up to six months post-treatment. Evaluations include standardized PTSD symptom checklists, anxiety and depression scales, sleep assessments, and satisfaction with therapy. Researchers will monitor participant progress with interviews and questionnaires to understand treatment impact, adherence, and overall acceptability. The total study duration spans roughly from March 2026 to August 2027, allowing comprehensive monitoring of effects and feasibility.

Age: 18Years +All GendersPhase Not Applicable
1 location

1-10 of 15

1